ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 17.12% of EVOK shares are held by financial institutions. VANGUARD GROUP INC is the top corporate investor, holding 1.12M shares valued at $553.00K. A 3.41% stake in Evoke Pharma, Inc. is owned by the company. GEODE CAPITAL MANAGEMENT, LLC owns 222.95K shares valued at $110.00K, which translates its holding of 0.68% of the stake in the company.
Among the EVOK insiders holding of 4.58% of the stake in company, DOMAIN PARTERS VII L P, 10 percent owner, holds the largest shares of 606.28K. GONYER DAVID A, President and CEO, is the second largest EVOK insider with ownership of 339.78K shares. D'ONOFRIO MATTHEW J, Exec VP, Chief Bus. Officer, stands third with possession of 284K shares of that stake.